Mentice AB (publ), a globally recognised leader in simulation solutions for image-guided interventional therapies, has announced a $642,000 order from a top 20 global Med Tech company, a long-standing and valued customer.
“We are proud to support our partner in advancing procedural training and patient care,” said Frans Venker, CEO of Mentice.
“This order reaffirms the growing reliance on simulation-based training and the strong commitment from medical technology companies to advance procedural safety and innovation.”
This order further strengthens Mentice's position as a trusted partner for global healthcare innovators."
"Through its advanced simulation solutions, Mentice remains dedicated to delivering evidence-based, clinically relevant solutions that support healthcare providers and MedTech companies in facilitating educational initiatives that drive progress in interventional therapies and optimise patient care."
The order will be recognised under the Mentice Medical Device Industry division in the coming months of 2025, contributing to the company’s growth strategy and expanding its presence in the market for interventional cardiology training solutions.